Differences in ex-vivo chemosensitivity to anthracyclines in first line acute myeloid leukemia

DISCUSSION:A third of the patients could benefit of the use of this test in the first line induction therapy selection, although it should be confirmed in a clinical trial specifically designed.
Source: Mediterranean Journal of Hematology and Infectious Diseases - Category: Hematology Source Type: research